Search

everythinglearnresearchcommunity

for

Search:↓

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Recent dermatological research highlights include new virus discoveries, genetic links to skin conditions, and insights into skin healing and pigmentation.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Vitamin D compounds may help treat psoriasis by promoting skin cell differentiation.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

FOXN1 gene variants cause low T cells and immune issues from birth.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

IL-17-producing γδ T cells help improve bone healing.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Early regulatory T cells are crucial for normal skin pigmentation.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

γδ T cells adapt uniquely to different tissues in mice.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.